A Critical Week for Beyond Meat: Delisting Threats, Delays, and Legal Action

Beyond Meat confronts a Nasdaq delisting warning, a delayed annual report, a class-action lawsuit, and its Q4 earnings call in a critical week for the struggling plant-based protein firm.

Beyond Meat is navigating a perfect storm of challenges this week, with multiple critical deadlines converging to put immense pressure on the plant-based protein pioneer. The company faces a potential stock delisting, a delayed annual report, a class-action lawsuit, and its quarterly earnings call—all within a narrow timeframe.

Financial Distress and Nasdaq Warnings

The company's shares are currently trading around $0.81, reflecting a staggering 76% decline over the past twelve months. This sustained low price has triggered formal delisting warnings from the Nasdaq exchange, as the stock has remained below the $1 threshold for more than 30 consecutive trading days. Market observers widely anticipate a reverse stock split as the most likely countermeasure. While such a move could technically stabilize the listing, it would do nothing to address the underlying business difficulties.

Those fundamental issues are severe. Beyond Meat reported losses of $238 million against revenue of $291 million in the last fiscal year. The financial deterioration has accelerated; for the first nine months of 2025, revenue contracted by over 14% year-over-year. Meanwhile, the operating loss more than doubled to $203 million.

Compounding these problems, the company has delayed filing its full annual report for 2025. The holdup stems from a need to re-evaluate inventory valuations and write-downs for obsolete stock. Management has indicated it expects to report a "material weakness" in internal financial controls. The complete 10-K filing is now due by March 31, 2026.

Preliminary figures are available, however. Fourth-quarter 2025 revenue is estimated at approximately $61 million, slightly below analyst expectations of $62.6 million. Full-year 2025 revenue is projected to be around $275 million.

Strategic Shifts Amid Structural Headwinds

In an attempt to revitalize its business, Beyond Meat is pursuing a rebranding and product diversification strategy. Now operating as "Beyond The Plant Protein Company," it launched a line of plant-based protein drinks called "Beyond Immerse" in January 2026. Analysts like those at Mizuho, who maintain an "Underperform" rating on the stock, interpret this expansion into active nutrition as a sign that the core plant-based meat business continues to struggle.

This pressure is structural. U.S. retail sales for plant-based meat have fallen significantly from their pandemic-era peak. A growing consumer perception of the products as highly processed, combined with the enduring price advantage of subsidized and scaled conventional meat, presents ongoing challenges.

A Confluence of Deadlines

The coming days present a tight sequence of critical events for the company and its investors. The deadline for investors to lead the class-action lawsuit is March 24. This legal action alleges disclosure deficiencies related to Beyond Meat's third-quarter 2025 results, when the company recorded $77.4 million in non-cash impairment charges on long-lived assets.

Immediately following, on March 25 after market close, the company will hold its earnings call. This discussion is expected to focus heavily on the inventory valuation issues and potential pathways to financial stabilization. Finally, the absolute deadline for the audited annual report submission is March 31. Three pivotal dates, one decisive week.